News|Articles|June 1, 2011

Formulary Digital Edition June 2011

Multiple sclerosis: A paradigm change with oral agents?; Focus On Telaprevir: A novel, protease inhibitor for the treatment of hepatitis C virus


Related to this article

Stafeeva-stock@adobe.com
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.